Notes from the Field: Long COVID Prevalence Among Adults — United States, 2022

Nicole D. Ford,Abraham Agedew,Alexandra F. Dalton,Jordan Singleton,Cria G. Perrine,Sharon Saydah

DOI: https://doi.org/10.15585/mmwr.mm7306a4

2024-02-16

MMWR Morbidity and Mortality Weekly Report

Abstract:This report describes the prevalence of adults who reported ever experiencing Long COVID.

public, environmental & occupational health

What problem does this paper attempt to address?

Long COVID and Significant Activity Limitation Among Adults, by Age — United States, June 1–13, 2022, to June 7–19, 2023

Nicole D. Ford,Douglas Slaughter,Deja Edwards,Alexandra Dalton,Cria Perrine,Anjel Vahratian,Sharon Saydah

DOI: https://doi.org/10.15585/mmwr.mm7232a3

2023-08-11

Abstract:Long COVID is a condition encompassing a wide range of health problems that emerge, persist, or return following COVID-19. CDC analyzed national repeat cross-sectional Household Pulse Survey data to estimate the prevalence of long COVID and significant related activity limitation among U.S. adults aged ≥18 years by age group. Data from surveys completed between June 1-13, 2022, and June 7-19, 2023, indicated that long COVID prevalence decreased from 7.5% (95% CI = 7.1-7.9) to 6.0% (95% CI = 5.7-6.3) among the overall U.S. adult population, irrespective of history of previous COVID-19, and from 18.9% (95% CI = 17.9-19.8) to 11.0% (95% CI = 10.4-11.6) among U.S. adults reporting previous COVID-19. Among both groups, prevalence decreased from June 1-13, 2022, through January 4-16, 2023, before stabilizing. When stratified by age, only adults aged <60 years experienced significant rates of decline (p<0.01). Among adults reporting previous COVID-19, prevalence decreased among those aged 30-79 years through fall or winter and then stabilized. During June 7-19, 2023, 26.4% (95% CI = 24.0-28.9) of adults with long COVID reported significant activity limitation, the prevalence of which did not change over time. These findings help guide the ongoing COVID-19 prevention efforts and planning for long COVID symptom management and future health care service needs.

public, environmental & occupational health
Prevalence and Factors Associated with Long COVID Symptoms among U.S. Adults, 2022

Kimberly H. Nguyen,Yingjun Bao,Julie Mortazavi,Jennifer D. Allen,Patricia O. Chocano-Bedoya,Laura Corlin

DOI: https://doi.org/10.3390/vaccines12010099

2024-01-19

Vaccines

Abstract:Long COVID and its symptoms have not been examined in different subpopulations of U.S. adults. Using the 2022 BRFSS (n = 445,132), we assessed long COVID and each symptom by sociodemographic characteristics and health-related variables. Multivariable logistic regression was conducted to examine factors associated with long COVID and the individual symptoms. Prevalence differences were conducted to examine differences in long COVID by vaccination status. Overall, more than one in five adults who ever had COVID-19 reported symptoms consistent with long COVID (21.8%). The most common symptom was tiredness or fatigue (26.2%), followed by difficulty breathing or shortness of breath (18.9%), and loss of taste or smell (17.0%). Long COVID was more common among adults under 65 years, women, American Indian or Alaska Native or other/multi race group, smokers, and people with a disability, depression, overweight or obesity compared to their respective counterparts. The prevalence of long COVID was higher among unvaccinated adults (25.6%) than vaccinated adults (21.6%) overall, and for 20 of 32 subgroups assessed. These findings underscore the benefits of vaccination, the importance of early treatment, and the need to better inform health care resource allocation and support services for those experiencing long COVID.

immunology,medicine, research & experimental
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

Hannah E. Davis,Gina S. Assaf,Lisa McCorkell,Hannah Wei,Ryan J. Low,Yochai Re'em,Signe Redfield,Jared P. Austin,Athena Akrami

DOI: https://doi.org/10.1016/j.eclinm.2021.101019

IF: 15.1

2021-08-01

EClinicalMedicine

Abstract:BackgroundA significant number of patients with COVID-19 experience prolonged symptoms, known as Long COVID. Few systematic studies have investigated this population, particularly in outpatient settings. Hence, relatively little is known about symptom makeup and severity, expected clinical course, impact on daily functioning, and return to baseline health.MethodsWe conducted an online survey of people with suspected and confirmed COVID-19, distributed via COVID-19 support groups (e.g. Body Politic, Long COVID Support Group, Long Haul COVID Fighters) and social media (e.g. Twitter, Facebook). Data were collected from September 6, 2020 to November 25, 2020. We analyzed responses from 3762 participants with confirmed (diagnostic/antibody positive; 1020) or suspected (diagnostic/antibody negative or untested; 2742) COVID-19, from 56 countries, with illness lasting over 28 days and onset prior to June 2020. We estimated the prevalence of 203 symptoms in 10 organ systems and traced 66 symptoms over seven months. We measured the impact on life, work, and return to baseline health.FindingsFor the majority of respondents (>91%), the time to recovery exceeded 35 weeks. During their illness, participants experienced an average of 55.9+/- 25.5 (mean+/-STD) symptoms, across an average of 9.1 organ systems. The most frequent symptoms after month 6 were fatigue, post-exertional malaise, and cognitive dysfunction. Symptoms varied in their prevalence over time, and we identified three symptom clusters, each with a characteristic temporal profile. 85.9% of participants (95% CI, 84.8% to 87.0%) experienced relapses, primarily triggered by exercise, physical or mental activity, and stress. 86.7% (85.6% to 92.5%) of unrecovered respondents were experiencing fatigue at the time of survey, compared to 44.7% (38.5% to 50.5%) of recovered respondents. 1700 respondents (45.2%) required a reduced work schedule compared to pre-illness, and an additional 839 (22.3%) were not working at the time of survey due to illness. Cognitive dysfunction or memory issues were common across all age groups (~88%). Except for loss of smell and taste, the prevalence and trajectory of all symptoms were similar between groups with confirmed and suspected COVID-19.InterpretationPatients with Long COVID report prolonged, multisystem involvement and significant disability. By seven months, many patients have not yet recovered (mainly from systemic and neurological/cognitive symptoms), have not returned to previous levels of work, and continue to experience significant symptom burden.FundingAll authors contributed to this work in a voluntary capacity. The cost of survey hosting (on Qualtrics) and publication fee was covered by AA's research grant (Wellcome Trust/Gatsby Charity via Sainsbury Wellcome center, UCL).
Prevalence and Determinants of Long-term Post-COVID Conditions in the United States: 2022 Behavioral Risk Factor Surveillance System

Seyyed Sina Hejazian,Alireza Vafaei Sadr,Shima Shahjouei,Ajith Vemuri,Vida Abedi,Ramin Zand

DOI: https://doi.org/10.1016/j.amjmed.2024.02.010

IF: 5.928

2024-02-22

The American Journal of Medicine

Abstract:BACKGROUND A significant proportion of COVID survivors experience lingering and debilitating symptoms following acute COVID-19 infection. According to the national research plan on long COVID , it is a national priority to identify the prevalence of post-COVID conditions and their associated factors. METHOD We performed a cross-sectional analysis of the Prevention Behavioral Risk Factor Surveillance System (BRFSS) 2022, the largest continuously gathered health survey dataset worldwide by the Centers for Disease Control. After identifying individuals with a positive history of COVID-19, we grouped COVID-19 survivors based on whether they experienced long-term post-COVID conditions. Using survey-specific R packages, we compared the two groups' socio-demographics, comorbidities, and lifestyle-related factors. A logistic regression model was used to identify factors associated with post-COVID conditions. RESULTS The overall estimated prevalence of long-term post-COVID conditions among COVID survivors was 21.7%. Fatigue(5.7%), dyspnea(4.2%), and anosmia/ageusia(3.8%) were the most frequent symptoms. Based on multivariate logistic regression analysis, female sex, body mass index (BMI)≥25, lack of insurance, history of pulmonary disease, depression, and arthritis, being a former smoker, and sleep duration 64 y/o, Black race, and annual household income≥$10000 were associated with lower odds of post-COVID conditions. CONCLUSION Our findings indicate a notable prevalence of post-COVID conditions, particularly among middle-aged women and individuals with comorbidities or adverse lifestyles. This high-risk demographic may require long-term follow-up and support. Further investigations are essential to facilitate the development of specified healthcare and therapeutic strategies for those suffering from post-COVID conditions.

medicine, general & internal
Attributes and predictors of long COVID

Carole H. Sudre,Benjamin Murray,Thomas Varsavsky,Mark S. Graham,Rose S. Penfold,Ruth C. Bowyer,Joan Capdevila Pujol,Kerstin Klaser,Michela Antonelli,Liane S. Canas,Erika Molteni,Marc Modat,M. Jorge Cardoso,Anna May,Sajaysurya Ganesh,Richard Davies,Long H. Nguyen,David A. Drew,Christina M. Astley,Amit D. Joshi,Jordi Merino,Neli Tsereteli,Tove Fall,Maria F. Gomez,Emma L. Duncan,Cristina Menni,Frances M. K. Williams,Paul W. Franks,Andrew T. Chan,Jonathan Wolf,Sebastien Ourselin,Tim Spector,Claire J. Steves

DOI: https://doi.org/10.1038/s41591-021-01292-y

IF: 82.9

2021-03-10

Nature Medicine

Abstract:Reports of long-lasting coronavirus disease 2019 (COVID-19) symptoms, the so-called 'long COVID', are rising but little is known about prevalence, risk factors or whether it is possible to predict a protracted course early in the disease. We analyzed data from 4,182 incident cases of COVID-19 in which individuals self-reported their symptoms prospectively in the COVID Symptom Study app<sup><a href="/articles/s41591-021-01292-y#ref-CR1">1</a></sup>. A total of 558 (13.3%) participants reported symptoms lasting ≥28 days, 189 (4.5%) for ≥8 weeks and 95 (2.3%) for ≥12 weeks. Long COVID was characterized by symptoms of fatigue, headache, dyspnea and anosmia and was more likely with increasing age and body mass index and female sex. Experiencing more than five symptoms during the first week of illness was associated with long COVID (odds ratio = 3.53 (2.76–4.50)). A simple model to distinguish between short COVID and long COVID at 7 days (total sample size, <i>n</i> = 2,149) showed an area under the curve of the receiver operating characteristic curve of 76%, with replication in an independent sample of 2,472 individuals who were positive for severe acute respiratory syndrome coronavirus 2. This model could be used to identify individuals at risk of long COVID for trials of prevention or treatment and to plan education and rehabilitation services.

biochemistry & molecular biology,cell biology,medicine, research & experimental
Long COVID prevalence and impact on quality of life 2 years after acute COVID-19

Yoonjung Kim,Sohyun Bae,Hyun-Ha Chang,Shin-Woo Kim

DOI: https://doi.org/10.1038/s41598-023-36995-4

IF: 4.6

2023-07-11

Scientific Reports

Abstract:Abstract There has been an increasing interest in the long-term impact of long COVID. However, only a few studies have investigated the clinical manifestations of long COVID 24 months after acute COVID infection. In this study, prospective online surveys were conducted in adults previously diagnosed with coronavirus disease 2019 (COVID-19) in South Korea between February 13 and March 13, 2020, at 6, 12, and 24 months after COVID-19. We investigated self-reported symptoms and the EuroQol-5-dimension index. Among 900 individuals enrolled initially, 150 completed all 3 surveys. After excluding the cases of COVID-19 reinfection, 132 individuals were included in the final analysis. Among the 132 participants, 94 (71.2%) experienced symptoms of long COVID. The most frequently reported symptoms were fatigue (34.8%), amnesia (30.3%), concentration difficulties (24.2%), insomnia (20.5%), and depression (19.7%). Notably, no significant differences were noted in the incidence of long COVID at 24 months in terms of the number of vaccinations received. Although the neuropsychiatric quality of life improved over time, it continued to affect 32.7% of participants. Symptoms of long COVID, particularly neuropsychiatric symptoms, tend to persist over time, and COVID-19 vaccination or the number of vaccinations received may not significantly affect the incidence of long COVID.

multidisciplinary sciences
Long covid—mechanisms, risk factors, and management

Harry Crook,Sanara Raza,Joseph Nowell,Megan Young,Paul Edison

DOI: https://doi.org/10.1136/bmj.n1648

2021-07-26

BMJ

Abstract:Abstract Since its emergence in Wuhan, China, covid-19 has spread and had a profound effect on the lives and health of people around the globe. As of 4 July 2021, more than 183 million confirmed cases of covid-19 had been recorded worldwide, and 3.97 million deaths. Recent evidence has shown that a range of persistent symptoms can remain long after the acute SARS-CoV-2 infection, and this condition is now coined long covid by recognized research institutes. Studies have shown that long covid can affect the whole spectrum of people with covid-19, from those with very mild acute disease to the most severe forms. Like acute covid-19, long covid can involve multiple organs and can affect many systems including, but not limited to, the respiratory, cardiovascular, neurological, gastrointestinal, and musculoskeletal systems. The symptoms of long covid include fatigue, dyspnea, cardiac abnormalities, cognitive impairment, sleep disturbances, symptoms of post-traumatic stress disorder, muscle pain, concentration problems, and headache. This review summarizes studies of the long term effects of covid-19 in hospitalized and non-hospitalized patients and describes the persistent symptoms they endure. Risk factors for acute covid-19 and long covid and possible therapeutic options are also discussed.
Symptoms and risk factors for long COVID in non-hospitalized adults

Anuradhaa Subramanian,Krishnarajah Nirantharakumar,Sarah Hughes,Puja Myles,Tim Williams,Krishna M. Gokhale,Tom Taverner,Joht Singh Chandan,Kirsty Brown,Nikita Simms-Williams,Anoop D. Shah,Megha Singh,Farah Kidy,Kelvin Okoth,Richard Hotham,Nasir Bashir,Neil Cockburn,Siang Ing Lee,Grace M. Turner,Georgios V. Gkoutos,Olalekan Lee Aiyegbusi,Christel McMullan,Alastair K. Denniston,Elizabeth Sapey,Janet M. Lord,David C. Wraith,Edward Leggett,Clare Iles,Tom Marshall,Malcolm J. Price,Steven Marwaha,Elin Haf Davies,Louise J. Jackson,Karen L. Matthews,Jenny Camaradou,Melanie Calvert,Shamil Haroon

DOI: https://doi.org/10.1038/s41591-022-01909-w

IF: 82.9

2022-07-26

Nature Medicine

Abstract:Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is associated with a range of persistent symptoms impacting everyday functioning, known as post-COVID-19 condition or long COVID. We undertook a retrospective matched cohort study using a UK-based primary care database, Clinical Practice Research Datalink Aurum, to determine symptoms that are associated with confirmed SARS-CoV-2 infection beyond 12 weeks in non-hospitalized adults and the risk factors associated with developing persistent symptoms. We selected 486,149 adults with confirmed SARS-CoV-2 infection and 1,944,580 propensity score-matched adults with no recorded evidence of SARS-CoV-2 infection. Outcomes included 115 individual symptoms, as well as long COVID, defined as a composite outcome of 33 symptoms by the World Health Organization clinical case definition. Cox proportional hazards models were used to estimate adjusted hazard ratios (aHRs) for the outcomes. A total of 62 symptoms were significantly associated with SARS-CoV-2 infection after 12 weeks. The largest aHRs were for anosmia (aHR 6.49, 95% CI 5.02–8.39), hair loss (3.99, 3.63–4.39), sneezing (2.77, 1.40–5.50), ejaculation difficulty (2.63, 1.61–4.28) and reduced libido (2.36, 1.61–3.47). Among the cohort of patients infected with SARS-CoV-2, risk factors for long COVID included female sex, belonging to an ethnic minority, socioeconomic deprivation, smoking, obesity and a wide range of comorbidities. The risk of developing long COVID was also found to be increased along a gradient of decreasing age. SARS-CoV-2 infection is associated with a plethora of symptoms that are associated with a range of sociodemographic and clinical risk factors.

biochemistry & molecular biology,cell biology,medicine, research & experimental
Factors Associated with Long COVID: Insights from Two Nationwide Surveys

Yixuan Wu,Mitsuaki Sawano,Yilun Wu,Rishi M Shah,Pamela Bishop,Akiko Iwasaki,Harlan M Krumholz,Rishi M. Shah,Harlan M. Krumholz

DOI: https://doi.org/10.1016/j.amjmed.2024.02.032

IF: 5.928

2024-03-15

The American Journal of Medicine

Abstract:Background : Long COVID is a multisystemic condition that affects the lives of millions of people globally, yet factors associated with it are poorly defined. Our purpose in this study was to identify factors associated with long COVID. Methods : This cross-sectional study used data from the 2022 Behavioral Risk Factor Surveillance System (BRFSS) and the 2022 National Health Interview Survey (NHIS). We restricted the sample to individuals aged 18 and older who reported a positive COVID-19 test or doctor's diagnosis. Individuals who reported symptoms of at least three months were assumed to have long COVID. We identified demographic and clinical characteristics associated with long COVID, in unadjusted and adjusted analyses. Results : The study included 124,313 individuals in the BRFSS cohort and 10,131 in the NHIS cohort who reported a COVID-19 infection, with 26,783 (21.5%) and 1797 (17.1%) reporting long COVID, respectively. We found middle age, female sex, lack of a college degree, and severity of acute COVID-19 infection to be associated with long COVID. In contrast, non-Hispanic Asian and Black Americans were less likely to report long COVID compared with non-Hispanic White individuals. These findings were consistent across datasets. Conclusions : Several demographic features were associated with long COVID, which may be the result of social, clinical, or biological influences.

medicine, general & internal
Prevalence of long COVID complaints in persons with and without COVID-19

Karin Magnusson,Aleksandra Turkiewicz,Signe Agnes Flottorp,Martin Englund

DOI: https://doi.org/10.1038/s41598-023-32636-y

IF: 4.6

2023-04-13

Scientific Reports

Abstract:Abstract We studied the prevalence and patterns of typical long COVID complaints in ~ 2.3 million individuals aged 18–70 years with and without confirmed COVID-19 in a Nation-wide population-based prospective cohort study in Norway. Our main outcome measures were the period prevalence of single-occurring or different combinations of complaints based on medical records: (1) Pulmonary (dyspnea and/or cough), (2) Neurological (concentration problems, memory loss), and/or (3) General complaints (fatigue). In persons testing positive (n = 75 979), 64 (95% confidence interval: 54 to 73) and 122 (111 to 113) more persons per 10 000 persons had pulmonary complaints 5–6 months after the test compared to 10 000 persons testing negative (n = 1 167 582) or untested (n = 1 084 578), respectively. The corresponding difference in prevalence of general complaints (fatigue) was 181 (168 to 195) and 224 (211 to 238) per 10 000, and of neurological complaints 5 (2 to 8) and 9 (6–13) per 10 000. Overlap between complaints was rare. Long COVID complaints were only slightly more prevalent in persons with than without confirmed COVID-19. Still, long COVID may pose a substantial burden to healthcare systems in the future given the lasting high incidence of symptomatic COVID-19 in both vaccinated and unvaccinated individuals.

multidisciplinary sciences
Prevalence of long COVID in the general adult population according to different definitions and sociodemographic and infection characteristics. A nationwide random sampling survey in France in autumn 2022

Joël Coste,Cyrille Delpierre,Jean-Baptiste Richard,Caroline Alleaume,Anne Gallay,Nathalie Beltzer,Sarah Tebeka,Cédric Lemogne,Olivier Robineau,Olivier Steichen,Tatjana T. Makovski

DOI: https://doi.org/10.2139/ssrn.4612725

IF: 13.31

2024-03-23

Clinical Microbiology and Infection

Abstract:Objectives Long COVID is recognized since early 2020, but its definition is not unanimous, which complicates epidemiological assessments. This study estimated the prevalence of long COVID based on several definitions and severity thresholds in the adult population in mainland France and examined variations according to sociodemographic and infection characteristics. Methods A cross-sectional survey using random sampling was conducted in August-November 2022. Participants declaring SARS-CoV-2 infection were assessed for infection dates and context, post-COVID symptoms (from a list of 31, with onset time, daily functioning impact, alternative diagnosis) and perceived long COVID. Long COVID prevalence was estimated according to the World Health Organisation (WHO), National Institute for Health and Care Excellence (NICE), United States National Centre for Health Statistics (US-NCHS) and United Kingdom Office for National Statistics (UK-ONS) definitions. Results Of 10,615 participants, 5,781 (54.5%) reported SARS-CoV-2 infection, with 123 to 759 (1.2% to 13.4%) having long COVID depending on the definition. Prevalence of WHO post-COVID condition (PCC) was 4.0% (95%CI:3.6-4.5) in the overall population and 8.0% (95%CI:7.0-8.9) among infected individuals. Among the latter, prevalence varied from 5.3% (men) to 14.9% (unemployed) and 18.6% (history of hospitalization for COVID-19). WHO-PCC overlapped poorly with other definitions (kappa ranging 0.18-0.59) and perceived long COVID (reported in only 43% of WHO-PCC). Conclusions Regardless of its definition, long COVID remains a significant burden in the French adult population that deserves surveillance, notably for forms that strongly impact daily activities. More standardised definitions will improve integrated surveillance of, and better research on, long COVID.

infectious diseases,microbiology
Persistent symptoms after COVID‐19: an Australian stratified random health survey on long COVID

Alex Holmes,Lance Emerson,Louis B Irving,Emma Tippett,Jeffrey M Pullin,Julie Young,David A Watters,Adina Hamilton

DOI: https://doi.org/10.5694/mja2.52473

2024-11-05

The Medical Journal of Australia

Abstract:Abstract Objective To determine the impact of persistent symptoms after coronavirus disease 2019 (COVID‐19) in an Australian population. Design, setting, participants We conducted a statewide health survey of a stratified random sample of adults who had had a confirmed acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection (COVID‐19‐positive group) and their close contacts (control group). The sample was drawn from Victoria's COVID‐19 database between January 2020 and October 2022. Data were collected from 12 688 survey respondents between September 2022 and April 2023 (11 174 in the COVID‐19‐positive group and 1514 in the control group). Main outcome measures Persistent new symptoms, recovery, and daily function using validated questionnaires for fatigue, neurocognitive symptoms, anxiety, depression and quality of life. Results At a mean of 12.6 months after infection, 4560 respondents in the COVID‐19‐positive group (39.1%; 95% CI, 37.9–40.3%) reported at least one persistent new symptom, compared with 216 respondents in the control group (20.8%; 95% CI, 18.5–23.1%). A total of 1656 respondents (14.2%; 95% CI, 13.4–15.0%) were classified as having clinical long COVID using the criteria of at least one persistent new symptom and less than 80% recovery three months after the infection. Of the respondents with clinical long COVID, 535 (3.2%; 95% CI, 2.6–3.8%) reported at least moderate problems with usual activities at 12 months after their infection. The proportion of respondents with clinical long COVID was lower for those with more recent infections. The risk factors for clinical long COVID were female sex, age 40–49 years, infection severity, chronic illness, and past anxiety or depression. Factors associated with a decreased risk of having clinical long COVID included infection when the Omicron strain was dominant and infection when the Delta strain was dominant, as compared with when the ancestral strain of the virus was dominant. Conclusion Persistent symptoms after COVID‐19 are common, though with a lower incidence following infection from less virulent strains. Although long COVID can be largely managed in primary care, a minority of people who have persistent symptoms and impaired function may require specialist care pathways, the effectiveness of which should be a focus of future research.

medicine, general & internal
Deep Dive into the Long Haul: Analysis of Symptom Clusters and Risk Factors for Post-Acute Sequelae of COVID-19 to Inform Clinical Care

Nicole H. Goldhaber,Jordan N. Kohn,William Scott Ogan,Amy Sitapati,Christopher A. Longhurst,Angela Wang,Susan Lee,Suzi Hong,Lucy E. Horton

DOI: https://doi.org/10.3390/ijerph192416841

IF: 4.614

2022-12-15

International Journal of Environmental Research and Public Health

Abstract:Long COVID is a chronic condition characterized by symptoms such as fatigue, dyspnea, and cognitive impairment that persist or relapse months after an acute infection with the SARS-CoV-2 virus. Many distinct symptoms have been attributed to Long COVID; however, little is known about the potential clustering of these symptoms and risk factors that may predispose patients to certain clusters. In this study, an electronic survey was sent to patients in the UC San Diego Health (UCSDH) system who tested positive for COVID-19, querying if patients were experiencing symptoms consistent with Long COVID. Based on survey results, along with patient demographics reported in the electronic health record (EHR), linear and logistic regression models were used to examine putative risk factors, and exploratory factor analysis was performed to determine symptom clusters. Among 999 survey respondents, increased odds of Long COVID (n = 421; 42%) and greater Long COVID symptom burden were associated with female sex (OR = 1.73, 99% CI: 1.16–2.58; β = 0.48, 0.22–0.75), COVID-19 hospitalization (OR = 4.51, 2.50–8.43; β = 0.48, 0.17–0.78), and poorer pre-COVID self-rated health (OR = 0.75, 0.57–0.97; β = −0.19, −0.32–−0.07). Over one-fifth of Long COVID patients screened positive for depression and/or anxiety, the latter of which was associated with younger age (OR = 0.96, 0.94–0.99). Factor analysis of 16 self-reported symptoms suggested five symptom clusters—gastrointestinal (GI), musculoskeletal (MSK), neurocognitive (NC), airway (AW), and cardiopulmonary (CP), with older age (β = 0.21, 0.11–0.30) and mixed race (β = 0.27, 0.04–0.51) being associated with greater MSK symptom burden. Greater NC symptom burden was associated with increased odds of depression (OR = 5.86, 2.71–13.8) and anxiety (OR = 2.83, 1.36–6.14). These results can inform clinicians in identifying patients at increased risk for Long COVID-related medical issues, particularly neurocognitive symptoms and symptom clusters, as well as informing health systems to manage operational expectations on a population-health level.

public, environmental & occupational health,environmental sciences
Long-COVID improves in 50% of patients after a year in a Midwestern cohort

Grant Stalker,Rosarie Tudas,Alpana Garg,Lauren Graham,Andrew L Thurman,R Todd Wiblin,Nabeel Hamzeh,Robert J Blount,Raul Villacreses,Joseph Zabner,Alejandro Comellas,Josalyn L Cho,Alejandro Pezzulo

DOI: https://doi.org/10.1101/2024.04.30.24306497

2024-05-01

MedRxiv

Abstract:Background: Many of those infected with COVID-19 experience long-term disability due to persistent symptoms known as Long-COVID, which include ongoing respiratory issues, loss of taste and smell, and impaired daily functioning. Research question: This study aims to better understand the chronology of long-COVID symptoms. Study design and methods: We prospectively enrolled 403 adults from the University of Iowa long-COVID clinic (June 2020 to February 2022). Participants provided symptom data during acute illness, symptom progression, and other clinical characteristics. Patients in this registry received a survey containing questions including current symptoms and status since long-COVID diagnosis (sliding status scale, PHQ2, GAD2, MMRC). Those >12 months since acute-COVID diagnosis had chart review done to track their symptomology. Results: Of 403 participants contacted, 129 (32%) responded. The mean age (in years) was 50.17 +/-14.28, with 31.8% male and 68.2% female. Severity of acute covid treatment was stratified by treatment in the outpatient (70.5%), inpatient (16.3%), or ICU (13.2%) settings. 51.2% reported subjective improvement (sliding scale scores of 67-100) since long-COVID onset. Ages 18-29 reported significantly higher subjective status scores. Subjective status scores were unaffected by severity. 102 respondents were >12 months from their initial COVID-19 diagnosis and were tracked for longitudinal symptom persistence. All symptoms tracked had variance (mean fraction 0.58, range 0.34-0.75) in the reported symptoms at the time of long-COVID presentation when compared with patient survey report. 48 reported persistent dyspnea, 23 (48%) had resolved it at time of survey. For fatigue, 44 had persistence, 12 (27%) resolved. Interpretation: Overall, 51.2% respondents improved since their long-COVID began. Pulmonary symptoms were more persistent than neuromuscular symptoms (anosmia, dysgeusia, myalgias). Gender, time since acute COVID infection, and its severity didn't affect subjective status or symptoms. This study highlights recall bias that may be prevalent in other long-COVID research reliant on participant memory.
Long COVID Prevalence, Disability, and Accommodations: Analysis Across Demographic Groups

Jennifer Cohen,Yana van der Meulen Rodgers

DOI: https://doi.org/10.1007/s10926-024-10173-3

2024-02-23

Journal of Occupational Rehabilitation

Abstract:This paper examines the prevalence of long COVID across different demographic groups in the US and the extent to which workers with impairments associated with long COVID have engaged in pandemic-related remote work.

rehabilitation,social issues
Prevalence, risk factors and characterisation of individuals with long COVID using Electronic Health Records in over 1.5 million COVID cases in England

Han-I Wang,Tim Doran,Michael G Crooks,Kamlesh Khunti,Melissa Heightman,Arturo Gonzalez-Izquierdo,Muhammad Qummer Ul Arfeen,Antony Loveless,Amitava Banerjee,Christina Van Der Feltz-Cornelis

DOI: https://doi.org/10.1016/j.jinf.2024.106235

2024-08-07

Abstract:Objectives: This study examines clinically confirmed long-COVID symptoms and diagnosis among individuals with COVID in England, aiming to understand prevalence and associated risk factors using electronic health records. To further understand long COVID, the study also explored differences in risks and symptom profiles in three subgroups: hospitalised, non-hospitalised, and untreated COVID cases. Methods: A population-based longitudinal cohort study was conducted using data from 1,554,040 individuals with confirmed SARS-CoV-2 infection via Clinical Practice Research Datalink. Descriptive statistics explored the prevalence of long COVID symptoms 12 weeks post-infection, and Cox regression models analysed the associated risk factors. Sensitivity analysis was conducted to test the impact of right-censoring data. Results: During an average 400-day follow-up, 7.4% of individuals with COVID had at least one long-COVID symptom after acute phase, yet only 0.5% had long-COVID diagnostic codes. The most common long-COVID symptoms included cough (17.7%), back pain (15.2%), stomach-ache (11.2%), headache (11.1%), and sore throat (10.0%). The same trend was observed in all three subgroups. Risk factors associated with long-COVID symptoms were female sex, non-white ethnicity, obesity, and pre-existing medical conditions like anxiety, depression, type II diabetes, and somatic symptom disorders. Conclusions: This study is the first to investigate the prevalence and risk factors of clinically confirmed long-COVID in the general population. The findings could help clinicians identify higher risk individuals for timely intervention and allow decision-makers to more efficiently allocate resources for managing long-COVID.
Associations Between Acute COVID-19 Symptom Profiles and Long COVID Prevalence: Population-Based Cross-Sectional Study

Jana L Hirschtick,Elizabeth Slocum,Yanmei Xie,Laura E Power,Michael R Elliott,Robert C Orellana,Nancy L Fleischer

DOI: https://doi.org/10.2196/55697

2024-10-02

JMIR Public Health and Surveillance

Abstract:Background: Growing evidence suggests that severe acute coronavirus disease 2019 (COVID-19) illness increases the risk of Long COVID. However, few studies have examined associations between acute symptoms and Long COVID onset. Objective: Our objective was to examine associations between acute COVID-19 symptom profiles and Long COVID prevalence using a population-based sample. Methods: We used a dual mode (phone and online) population-based probability survey of adults with PCR-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) between June 2020 and May 2022 in the Michigan Disease Surveillance System to examine 1) how acute COVID-19 symptoms cluster together using latent class analysis; 2) sociodemographic and clinical predictors of symptom clusters using multinomial logistic regression accounting for classification uncertainties; and 3) associations between symptom clusters and Long COVID prevalence using modified Poisson regression. Results: In our sample (n=4,169), 15.9% had Long COVID, defined as new or worsening symptoms at least 90 days post SARS-CoV-2 infection. We identified six acute COVID-19 symptom clusters, with flu-like symptoms (24.7%) and fever (23.6%) most prevalent in our sample, followed by nasal congestion (16.4%), multi-symptomatic (14.5%), predominance of fatigue (10.8%), and predominance of shortness of breath (10.0%) clusters. Long COVID prevalence was highest in the multisymptomatic (39.7%) and predominance of shortness of breath (22.4%) clusters, followed by flu-like (15.8%), predominance of fatigue (14.5%), fever (6.4%), and nasal congestion (5.6%) clusters. After adjustment, females (vs. males) had greater odds of membership in the multi-symptomatic, flu-like, and predominance of fatigue clusters, while adults who were Hispanic or another race/ethnicity (vs. non-Hispanic white) had greater odds of membership in the multi-symptomatic cluster. Compared to the nasal congestion cluster, the multi-symptomatic cluster had the highest prevalence of Long COVID (aPR 6.1, 95% CI 4.3-8.7), followed by predominance of shortness of breath (aPR 3.7, 95% CI 2.5-5.5), flu-like symptoms (aPR 2.8, 95% CI 1.9-4.0), and predominance of fatigue (aPR 2.2, 95% CI 1.5-3.3) clusters. Conclusions: Researchers and clinicians should consider acute COVID-19 symptom profiles when evaluating subsequent risk of Long COVID, including potential mechanistic pathways in a research context, and proactively screening high risk patients during the provision of clinical care.

public, environmental & occupational health
Long-term health impacts of COVID-19 among 242,712 adults in England

Christina J. Atchison,Bethan Davies,Emily Cooper,Adam Lound,Matthew Whitaker,Adam Hampshire,Adriana Azor,Christl A. Donnelly,Marc Chadeau-Hyam,Graham S. Cooke,Helen Ward,Paul Elliott

DOI: https://doi.org/10.1038/s41467-023-41879-2

IF: 16.6

2023-10-24

Nature Communications

Abstract:Abstract The COVID-19 pandemic is having a lasting impact on health and well-being. We compare current self-reported health, quality of life and symptom profiles for people with ongoing symptoms following COVID-19 to those who have never tested positive for SARS-CoV-2 infection and those who have recovered from COVID-19. Overall, 276,840/800,000 (34·6%) of invited participants took part. Mental health and health-related quality of life were worse among participants with ongoing persistent symptoms post-COVID compared with those who had never had COVID-19 or had recovered. In this study, median duration of COVID-related symptoms (N = 130,251) was 1·3 weeks (inter-quartile range 6 days to 2 weeks), with 7·5% and 5·2% reporting ongoing symptoms ≥12 weeks and ≥52 weeks respectively. Female sex, ≥1 comorbidity and being infected when Wild-type variant was dominant were associated with higher probability of symptoms lasting ≥12 weeks and longer recovery time in those with persistent symptoms. Although COVID-19 is usually of short duration, some adults experience persistent and burdensome illness.

multidisciplinary sciences
Prevalence, clinical manifestations, and associated factors of long COVID-19

Daniel Rojas-Bolivar,Fabiola Huaroto-Ramírez,Maricela Curisinche-Rojas,Diana Gonzales Zurita,Ericson Gutiérrez

DOI: https://doi.org/10.25176/rfmh.v22i3.5009

2022-07-09

Revista de la Facultad de Medicina Humana

Abstract:The aim was to describe the prevalence, clinical manifestations, and associated factors of long-COVID. Bibliographic research of systematic reviews and meta-analyses was carried out in MEDLINE (through PubMed) until April 7th, 2022. 37 articles were found and 3 were included. Evidence quality was assessed via AMSTAR 2 criteria. Long-COVID prevalence is 43% (IC95%: 39% – 46%). Main clinical manifestations were weakness (41% [IC95%: 25% – 59%]), malaise (33% [IC95%: 15% – 57%]), fatigue (31% [IC95%: 24% – 39%]), concentration impairment (26% [IC95%: 21% – 32%]), and breathlessness (25% [IC95%: 18% – 34%]). Factors associated with long COVID were female sex, initial disease severity, age, and presence of comorbidities.
Long COVID Illness: Disparities in Understanding and Receipt of Care in Emergency Department Populations

Robert M Rodriguez,Karen Reyes,Vijaya Arun Kumar,Brian Chinnock,Stephanie A Eucker,Kristin L Rising,Zubaid Rafique,Michael Gottlieb,Graham Nichol,Dana Morse,Melanie Molina,Mireya I Arreguin,Lindsey Shughart,Christopher Conn,Svea Eckstrand,Heba Mesbah,Lauren Chakraborty,Robert D Welch

DOI: https://doi.org/10.1016/j.annemergmed.2024.07.009

2024-09-24

Abstract:Study objective: Most long coronavirus disease (long COVID) studies rely on traditional surveillance methods that miss underserved populations who use emergency departments (EDs) as their primary health care source. In medically underserved ED populations, we sought to determine (1) whether there are gaps in awareness and self-declared understanding about long COVID illness, and (2) the prevalence, impact on school/work attendance, and receipt of care for long COVID symptoms. Methods: This study was a cross-sectional, convenience sample survey study of adult patients at 11 geographically representative US EDs from December 2022 to October 2023. Awareness and self-declared understanding about long COVID illness were measured. Prevalence, impact on school/work attendance, and receipt of care for long COVID symptoms were also assessed. Results: Of 1,618 eligible patients, 1455 (89.9%) agreed to participate, including 33.4% African Americans and 30.9% Latino/a. Of the patients, 17.1% lacked primary care. In total, 33.2% had persistent COVID-19 symptoms lasting >1 month, and 20.3% had symptoms >3 months. Moreover, 49.8% with long COVID symptoms missed work/school because of symptoms; 30.3% of all participants and 33.5% of participants who had long COVID symptoms had prior awareness and self-declared understanding of long COVID. Characteristics associated with poor understanding of long COVID were African American race (adjusted odds ratio [aOR] 3.68, 95% confidence interval [CI] 2.66 to 5.09) and Latino/a ethnicity (aOR 3.16, 95% CI 2.15 to 4.64). Participants lacking primary care were less likely to have received long COVID care (24.6% versus 51.2%; difference 26.6%; 95% CI 13.7% to 36.9%). Conclusions: Despite high prevalence and impact on school/work attendance of long COVID symptoms, most of this ED population had limited awareness and self-declared understanding of long COVID, and many had not received care. EDs should consider the development of protocols for diagnosis, education, and treatment of long COVID illness.

Notes from the Field: Long COVID Prevalence Among Adults — United States, 2022

Long COVID and Significant Activity Limitation Among Adults, by Age — United States, June 1–13, 2022, to June 7–19, 2023

Prevalence and Factors Associated with Long COVID Symptoms among U.S. Adults, 2022

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

Prevalence and Determinants of Long-term Post-COVID Conditions in the United States: 2022 Behavioral Risk Factor Surveillance System

Attributes and predictors of long COVID

Long COVID prevalence and impact on quality of life 2 years after acute COVID-19

Long covid—mechanisms, risk factors, and management

Symptoms and risk factors for long COVID in non-hospitalized adults

Factors Associated with Long COVID: Insights from Two Nationwide Surveys

Prevalence of long COVID complaints in persons with and without COVID-19

Prevalence of long COVID in the general adult population according to different definitions and sociodemographic and infection characteristics. A nationwide random sampling survey in France in autumn 2022

Persistent symptoms after COVID‐19: an Australian stratified random health survey on long COVID

Deep Dive into the Long Haul: Analysis of Symptom Clusters and Risk Factors for Post-Acute Sequelae of COVID-19 to Inform Clinical Care

Long-COVID improves in 50% of patients after a year in a Midwestern cohort

Long COVID Prevalence, Disability, and Accommodations: Analysis Across Demographic Groups

Prevalence, risk factors and characterisation of individuals with long COVID using Electronic Health Records in over 1.5 million COVID cases in England

Associations Between Acute COVID-19 Symptom Profiles and Long COVID Prevalence: Population-Based Cross-Sectional Study

Long-term health impacts of COVID-19 among 242,712 adults in England

Prevalence, clinical manifestations, and associated factors of long COVID-19

Long COVID Illness: Disparities in Understanding and Receipt of Care in Emergency Department Populations